Gastroenterologist to know: Dr. John Affronti of Tulane University School of Medicine

John P. Affronti, MD, is the interim chief of the gastroenterology and hepatology department at Tulane University School of Medicine in New Orleans.

Advertisement

Dr. Affronti’s clinical interests include colonoscopy, endoscopy, esophagoscopy, colorectal cancer, colon cancer and endoscopic ultrasound, among others. He also has experience treating biliary and pancreatic disorders.

Previously, Dr. Affronti served as director of endoscopy at the University of Florida in Jacksonville, where he set up the institution’s first endoscopic ultrasound program. In 2013, the Medical College of Georgia in August recruited him to develop the advanced endoscopy program at the institute’s new Digestive Health Center. While there, he served as director of the advanced endoscopy and gastrointestinal services.

Dr. Affronti earned his medical degree from George Washington University in Washington, D.C., where he also completed his residency. He underwent his gastroenterology fellowship at Duke University in Durham, N.C.

More articles on GI & endoscopy:
Cary Gastroenterology, Smart Clinic sign agreement — 5 observations
The Leading Physicians of the World to publish Dr. David Carr-Locke’s research — 5 highlights
Gastroenterologist to know: Dr. John Leung of Tufts Medical Center

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.